- Home
- MHLD vs COYA Comparison
MHLD vs COYA Comparison
Compare MHLD & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MHLD
- COYA
- Stock Information
- Founded
- MHLD 2007
- COYA 2020
- Country
- MHLD Bermuda
- COYA United States
- Employees
- MHLD N/A
- COYA N/A
- Industry
- MHLD Property-Casualty Insurers
- COYA Biotechnology: Pharmaceutical Preparations
- Sector
- MHLD Finance
- COYA Health Care
- Exchange
- MHLD Nasdaq
- COYA Nasdaq
- Market Cap
- MHLD 96.4M
- COYA 108.4M
- IPO Year
- MHLD 2008
- COYA 2022
- Fundamental
- Price
- MHLD $0.59
- COYA $6.47
- Analyst Decision
- MHLD
- COYA Strong Buy
- Analyst Count
- MHLD 0
- COYA 4
- Target Price
- MHLD N/A
- COYA $17.00
- AVG Volume (30 Days)
- MHLD 165.4K
- COYA 91.9K
- Earning Date
- MHLD 03-10-2025
- COYA 03-18-2025
- Dividend Yield
- MHLD N/A
- COYA N/A
- EPS Growth
- MHLD N/A
- COYA N/A
- EPS
- MHLD N/A
- COYA N/A
- Revenue
- MHLD $56,436,000.00
- COYA $3,554,061.00
- Revenue This Year
- MHLD N/A
- COYA $61.45
- Revenue Next Year
- MHLD N/A
- COYA N/A
- P/E Ratio
- MHLD N/A
- COYA N/A
- Revenue Growth
- MHLD N/A
- COYA N/A
- 52 Week Low
- MHLD $0.57
- COYA $4.75
- 52 Week High
- MHLD $2.27
- COYA $10.24
- Technical
- Relative Strength Index (RSI)
- MHLD 33.88
- COYA 48.49
- Support Level
- MHLD $0.67
- COYA $6.36
- Resistance Level
- MHLD $0.75
- COYA $7.06
- Average True Range (ATR)
- MHLD 0.06
- COYA 0.44
- MACD
- MHLD -0.01
- COYA -0.02
- Stochastic Oscillator
- MHLD 0.00
- COYA 32.95
About MHLD Maiden Holdings Ltd.
Maiden Holdings Ltd provides reinsurance products and services to regional and specialty property and casualty insurers. The company operates in two segments: AmTrust Reinsurance and Diversified Reinsurance. The AmTrust Reinsurance segment provides products that cover workers' compensation, commercial package, commercial auto, and extended warranty. The Diversified Reinsurance segment provides small and midsize regional and specialty insurers with reinsurance capital products. Its revenues also include fee income earned from both its GLS business and IIS business as well as income generated from its investment portfolio.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.